Breaking News Instant updates and real-time market news.

HLNE

Hamilton Lane

$77.43 /

-1.075 (-1.37%)

07:10
02/08/23
02/08
07:10
02/08/23
07:10

Hamilton Lane price target raised to $75 from $69 at Wells Fargo

Wells Fargo analyst Finian O'Shea raised the firm's price target on Hamilton Lane to $75 from $69 and keeps an Equal Weight rating on the shares following a solid Q3 except for an investment write-down. The firm is trimming out-year EPS estimates a bit on assumed slower margin expansion.

OTHER BREAKING NEWS FROM THE FLY

Initiation
Teleflex assumed with an Equal Weight at Morgan Stanley » 06:54
05/30/23
05/30
06:54
05/30/23
06:54
TFX

Teleflex

$232.54 /

-0.87 (-0.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54

Get Free Trial

ShowHide Related Items >><<
TFX Teleflex
$232.54 /

-0.87 (-0.37%)

TFX Teleflex
$232.54 /

-0.87 (-0.37%)

04/26/23 Wolfe Research
Teleflex downgraded to Peer Perform from Outperform at Wolfe Research
04/18/23 Mizuho
Teleflex price target raised to $250 from $220 at Mizuho
04/17/23 Truist
Teleflex price target raised to $264 from $250 at Truist
12/28/22 Stephens
Teleflex price target raised to $295 from $280 at Stephens
TFX Teleflex
$232.54 /

-0.87 (-0.37%)

Initiation
Edwards Lifesciences assumed with an Overweight at Morgan Stanley » 06:54
05/30/23
05/30
06:54
05/30/23
06:54
EW

Edwards Lifesciences

$82.00 /

+0.32 (+0.39%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

05/18/23 Truist
Edwards Lifesciences price target raised to $101 from $97 at Truist
04/28/23 Barclays
Edwards Lifesciences price target raised to $102 from $94 at Barclays
04/27/23 Wells Fargo
Edwards Lifesciences price target raised to $90 from $78 at Wells Fargo
04/27/23 Piper Sandler
Edwards Lifesciences price target raised to $83 from $80 at Piper Sandler
EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

Initiation
ShockWave Medical assumed with an Equal Weight at Morgan Stanley » 06:53
05/30/23
05/30
06:53
05/30/23
06:53
SWAV

ShockWave Medical

/

+

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

05/12/23 Piper Sandler
Piper continues to view ShockWave Medical as 'highly coveted asset'
05/09/23 Deutsche Bank
ShockWave Medical price target raised to $310 from $285 at Deutsche Bank
05/09/23 Needham
ShockWave Medical price target raised to $325 from $283 at Needham
05/09/23 Piper Sandler
ShockWave Medical price target raised to $315 from $280 at Piper Sandler
SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

Recommendations
Lincoln Electric price target raised to $200 from $184 at Baird » 06:53
05/30/23
05/30
06:53
05/30/23
06:53
LECO

Lincoln Electric

$173.52 /

+2.76 (+1.62%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53

Get Free Trial

ShowHide Related Items >><<
LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

05/02/23 Barclays
Lincoln Electric price target raised to $185 from $145 at Barclays
04/28/23 Oppenheimer
Lincoln Electric price target raised to $180 from $177 at Oppenheimer
04/27/23 Baird
Lincoln Electric price target raised to $184 from $180 at Baird
04/17/23 Stifel
Lincoln Electric price target raised to $176 from $173 at Stifel
LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

Initiation
Boston Scientific assumed with an Overweight at Morgan Stanley » 06:52
05/30/23
05/30
06:52
05/30/23
06:52
BSX

Boston Scientific

$51.05 /

-0.49 (-0.95%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52

Get Free Trial

ShowHide Related Items >><<
BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

05/16/23 BofA
BofA says Boston Scientific Watchman label update important, ups target
04/27/23 Stifel
Boston Scientific price target raised to $58 from $52 at Stifel
04/27/23 RBC Capital
Boston Scientific price target raised to $56 from $53 at RBC Capital
04/27/23 Deutsche Bank
Boston Scientific price target raised to $55 from $45 at Deutsche Bank
BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

Initiation
Bausch + Lomb assumed with an Equal Weight at Morgan Stanley » 06:52
05/30/23
05/30
06:52
05/30/23
06:52
BLCO

Bausch + Lomb

$17.92 /

-0.58 (-3.14%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52

Get Free Trial

ShowHide Related Items >><<
BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

05/22/23 Jefferies
Bausch Health price target raised to $9.50 from $7 at Jefferies
05/19/23 H.C. Wainwright
Bausch + Lomb price target raised to $22 from $19 at H.C. Wainwright
05/18/23 Wells Fargo
Bausch + Lomb has 'significant opportunity' with Miebo, says Wells Fargo
05/17/23 RBC Capital
District Court ruling positive for Bausch Health and Bausch + Lomb, says RBC
BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

Initiation
Alcon assumed with an Equal Weight at Morgan Stanley » 06:51
05/30/23
05/30
06:51
05/30/23
06:51
ALC

Alcon

$79.06 /

+0.78 (+1.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:51

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$79.06 /

+0.78 (+1.00%)

ALC Alcon
$79.06 /

+0.78 (+1.00%)

05/24/23 Barrington
Lifecore price target raised to $10 from $8 at Barrington
05/23/23 Stephens
Lifecore 'now a much cleaner story,' says Stephens
05/11/23 JPMorgan
Alcon price target raised to CHF 71 from CHF 63.80 at JPMorgan
05/11/23 Mizuho
Alcon price target raised to $95 from $85 at Mizuho
ALC Alcon
$79.06 /

+0.78 (+1.00%)

ALC Alcon
$79.06 /

+0.78 (+1.00%)

Recommendations
Google AI chip orders accelerating at Broadcom, says JPMorgan » 06:50
05/30/23
05/30
06:50
05/30/23
06:50
AVGO

Broadcom

$812.72 /

+84.07 (+11.54%)

, GOOG

Alphabet

$125.37 /

+1.04 (+0.84%)

, GOOGL

Alphabet

$124.62 /

+1.14 (+0.92%)

, META

Meta Platforms

$262.01 /

+9.33 (+3.69%)

JPMorgan analyst Harlan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:50

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/26/23 Oppenheimer
Broadcom price target raised to $800 from $720 at Oppenheimer
05/25/23 BofA
Nvidia price target raised to $450 from $340 at BofA
05/25/23 Susquehanna
Broadcom price target raised to $785 from $690 at Susquehanna
GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/24/23 BofA
Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA
05/24/23 BofA
Partnership with Waymo 'positive for Uber on several fronts,' says BofA
05/23/23 Jefferies
Alphabet price target raised to $150 from $130 at Jefferies
GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/24/23 BofA
Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA
05/24/23 BofA
Partnership with Waymo 'positive for Uber on several fronts,' says BofA
05/23/23 Jefferies
Alphabet price target raised to $150 from $130 at Jefferies
META Meta Platforms
$262.01 /

+9.33 (+3.69%)

05/23/23 Piper Sandler
Meta's AI initiatives could drive revenue recapture, says Piper Sandler
05/23/23 Citi
Citi sees minimal risk to Meta Platforms after E.U. data fine
05/22/23 Evercore ISI
Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI
05/19/23 Roth MKM
Meta Platforms' capex may decline in 2023-2024, says Roth MKM
AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

Hot Stocks
Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial » 06:49
05/30/23
05/30
06:49
05/30/23
06:49
PFE

Pfizer

$37.59 /

-0.245 (-0.65%)

Pfizer announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:49

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

05/23/23 Jefferies
Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note'
05/22/23
Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says
05/19/23 BofA
AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA
05/16/23 Stifel
Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel
PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

Initiation
Baxter assumed with an Equal Weight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BAX

Baxter

$41.29 /

-0.055 (-0.13%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

05/01/23 Barclays
Baxter price target raised to $58 from $54 at Barclays
04/28/23 Stifel
Baxter price target raised to $54 from $45 at Stifel
04/28/23 Deutsche Bank
Baxter price target raised to $50 from $40 at Deutsche Bank
04/28/23 TD Cowen
Baxter price target raised to $50 from $45 at TD Cowen
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

Initiation
Becton Dickinson assumed with an Overweight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BDX

Becton Dickinson

$241.13 /

-0.49 (-0.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

05/08/23 Barclays
Becton Dickinson price target raised to $284 from $282 at Barclays
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight after pullback at Piper Sandler
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight from Neutral at Piper Sandler
04/12/23 KeyBanc
Becton Dickinson upgraded to Overweight from Sector Weight at KeyBanc
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

Hot Stocks
Team regains NYSE compliance » 06:47
05/30/23
05/30
06:47
05/30/23
06:47
TISI

Team

$8.10 /

+1.08 (+15.38%)

Team announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:47

Get Free Trial

ShowHide Related Items >><<
TISI Team
$8.10 /

+1.08 (+15.38%)

Hot Stocks
Golden Minerals to effect 1-for-25 reverse stock split » 06:46
05/30/23
05/30
06:46
05/30/23
06:46
AUMN

Golden Minerals

/

+

Golden Minerals announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:46

Get Free Trial

ShowHide Related Items >><<
AUMN Golden Minerals
/

+

AUMN Golden Minerals
/

+

03/24/23 Alliance Global Partners
Golden Minerals price target lowered to 80c from $1.10 at Alliance Global
08/04/22 H.C. Wainwright
Golden Minerals price target lowered to 60c from $1 at H.C. Wainwright
Recommendations
PayPal recent weakness should be bought, says Mizuho » 06:45
05/30/23
05/30
06:45
05/30/23
06:45
PYPL

PayPal

$60.22 /

+0.835 (+1.41%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:45

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

05/22/23 Bernstein
PayPal price target lowered to $70 from $85 at Bernstein
05/19/23 Morgan Stanley
Morgan Stanley says proposed 1099-K legislation 'incremental positive' for Block
05/12/23 Exane BNP Paribas
PayPal downgraded to Neutral from Outperform at Exane BNP Paribas
05/11/23 Barclays
PayPal price target lowered to $92 from $108 at Barclays
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

Recommendations
Lantheus selloff on competitor approval overdone, says Mizuho » 06:42
05/30/23
05/30
06:42
05/30/23
06:42
LNTH

Lantheus

$91.06 /

-6.855 (-7.00%)

Mizuho views…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42

Get Free Trial

ShowHide Related Items >><<
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

05/05/23 SVB Securities
Lantheus price target raised to $127 from $120 at SVB Securities
05/05/23 Truist
Lantheus price target raised to $125 from $115 at Truist
05/05/23 JMP Securities
Lantheus price target raised to $130 from $120 at JMP Securities
05/05/23 Mizuho
Lantheus price target raised to $125 from $115 at Mizuho
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

Recommendations
Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
OHI

Omega Healthcare

$28.34 /

+0.25 (+0.89%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

05/03/23 Stifel
Omega Healthcare price target lowered to $33 from $36 at Stifel
04/19/23 Wells Fargo
Omega Healthcare initiated with an Overweight at Wells Fargo
01/13/23 Baird
Omega Healthcare price target lowered to $29 from $32 at Baird
01/09/23 Credit Suisse
Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

Recommendations
Ventas price target lowered to $53 from $60 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
VTR

Ventas

$42.87 /

+0.045 (+0.11%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$42.87 /

+0.045 (+0.11%)

VTR Ventas
$42.87 /

+0.045 (+0.11%)

04/25/23 Barclays
Ventas price target lowered to $55 from $57 at Barclays
04/19/23 Wells Fargo
Wells Fargo starts Ventas with Overweight on senior housing growth
04/19/23 Wells Fargo
Ventas initiated with an Overweight at Wells Fargo
04/12/23 Credit Suisse
Ventas price target lowered to $50 from $51 at Credit Suisse
VTR Ventas
$42.87 /

+0.045 (+0.11%)

Recommendations
Welltower price target lowered to $86 from $91 at Mizuho » 06:38
05/30/23
05/30
06:38
05/30/23
06:38
WELL

Welltower

$73.54 /

-0.07 (-0.10%)

Mizuho lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:38

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

05/24/23 Deutsche Bank
Deutsche ups target on 'must-own' Welltower to $84 from $81
05/16/23 RBC Capital
Welltower price target raised to $87 from $82 at RBC Capital
04/19/23 Wells Fargo
Wells Fargo starts Ventas with Overweight on senior housing growth
04/19/23 Wells Fargo
Welltower initiated with an Overweight at Wells Fargo
WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

Recommendations
Xcel Energy price target lowered to $69 from $72 at Mizuho » 06:36
05/30/23
05/30
06:36
05/30/23
06:36
XEL

Xcel Energy

$64.34 /

+0.06 (+0.09%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:36

Get Free Trial

ShowHide Related Items >><<
XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

04/05/23 BMO Capital
Xcel Energy price target lowered to $73 from $74 at BMO Capital
03/17/23 Mizuho
Xcel Energy price target lowered to $72 from $75 at Mizuho
12/14/22 Wells Fargo
Xcel Energy price target raised to $76 from $69 at Wells Fargo
11/21/22 Credit Suisse
Xcel Energy downgraded to Neutral from Outperform at Credit Suisse
XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

Recommendations
C4 Therapeutics price target lowered to $10, transferred at Evercore ISI » 06:35
05/30/23
05/30
06:35
05/30/23
06:35
CCCC

C4 Therapeutics

$3.08 /

-0.015 (-0.48%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:35

Get Free Trial

ShowHide Related Items >><<
CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

05/08/23 H.C. Wainwright
C4 Therapeutics price target lowered to $25 from $35 at H.C. Wainwright
03/28/23 BofA
C4 Therapeutics price target lowered to $5 from $11 at BofA
02/24/23 Credit Suisse
Credit Suisse ups C4 Therapeutics to Neutral on 'dramatically' improved outlook
02/24/23 Credit Suisse
C4 Therapeutics upgraded to Neutral from Underperform at Credit Suisse
CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

Recommendations
Salesforce price target raised to $250 from $225 at Wells Fargo » 06:33
05/30/23
05/30
06:33
05/30/23
06:33
CRM

Salesforce

$215.46 /

+5.58 (+2.66%)

Wells Fargo raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

06:13 Today Canaccord
Salesforce price target raised to $230 from $215 at Canaccord
05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/26/23 Citi
Salesforce price target raised to $229 from $210 at Citi
05/25/23 Wedbush
Salesforce price target raised to $230 from $220 at Wedbush
CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

Upgrade
BofA upgrades ChargePoint to Buy with shares at all-time lows » 06:33
05/30/23
05/30
06:33
05/30/23
06:33
CHPT

ChargePoint

$8.50 /

+0.175 (+2.10%)

BofA analyst Alex Vrabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33

Get Free Trial

ShowHide Related Items >><<
CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

06:05 Today BofA
ChargePoint upgraded to Buy from Neutral at BofA
05/08/23 B. Riley
ChargePoint price target lowered to $12 from $18 at B. Riley
05/02/23 Guggenheim
ChargePoint initiated with a Neutral at Guggenheim
04/25/23 Stifel
Wallbox price target lowered to $9 from $14 at Stifel
CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

Earnings
Skyline Champion reports Q4 EPS $1.00, consensus 93c » 06:32
05/30/23
05/30
06:32
05/30/23
06:32
SKY

Skyline Champion

$64.49 /

+0.435 (+0.68%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:32

Get Free Trial

ShowHide Related Items >><<
SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

02/08/23 Craig-Hallum
Skyline Champion price target raised to $78 from $65 at Craig-Hallum
02/08/23 RBC Capital
Skyline Champion price target raised to $65 from $54 at RBC Capital
12/30/22 Wedbush
Wedbush favors four homebuilding stocks heading into 2023
12/14/22 Barclays
Skyline Champion downgraded to Equal Weight from Overweight at Barclays
SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

Hot Stocks
SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled » 06:31
05/30/23
05/30
06:31
05/30/23
06:31
SWTX

SpringsWorks Therapeutics

$27.79 /

-2.18 (-7.27%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:31

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

04/28/23 Barclays
SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays
03/07/23 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA
SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

Recommendations
ServiceNow price target raised to $665 from $586 at Bernstein » 06:30
05/30/23
05/30
06:30
05/30/23
06:30
NOW

ServiceNow

$537.41 /

+5.65 (+1.06%)

Bernstein analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:30

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/18/23 Barclays
ServiceNow price target raised to $559 from $551 at Barclays
05/17/23 Goldman Sachs
Goldman Sachs increasingly positive on ServiceNow after Analyst Day
05/17/23 Piper Sandler
Piper says 'don't split hairs,' buy ServiceNow shares
NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.